Epidermolysis Bullosa (EB), or butterfly disease, affects 1 in 50,000 people, causing fragile skin that blisters easily, often likened to the delicacy of butterfly wings.

Argyria is caused by a buildup of silver in the body, which discolors the skin. Symptoms: The main symptoms of argyria are the skin developing a bluish-gray or gray tint, the fingernails growing ...

D.C.’s Vanda Pharmaceuticals Inc. has locked in a deal with a West Coast biotech to commercialize a drug for a rare skin ...

Sanofi and Regeneron's Dupixent has become the first biologic drug to show activity in prurigo nodularis (PN), raising the hope of a new treatment option for the rare and highly debilitating skin ...

Mayo Clinic researchers have identified a targeted therapy that could bring relief to people living with lichen planus, a ...

DEBRA Research and LEO Pharma enter strategic partnership to advance treatments for rare skin diseases: Munich, Germany Thursday, February 6, 2025, 10:00 Hrs [IST] DEBRA Research ...

Her story of bringing up children who suffer from ichthyosis, a rare skin disease, has redefined motherhood for her. She describes it as a journey full of confusion, tears and desperately seeking ...

One in every 10 people worldwide is impacted by a rare genetic disease but about 50% of them remain undiagnosed despite rapid ...

Pioglitazone was associated with a lower risk of developing skin ulcers in patients with Werner disease in a Japanese study, ...

royalty-bearing license to its technology for use in select rare skin diseases and for the right to use its proprietary formula for Netherton Syndrome. Netherton Syndrome is a hereditary disorder ...

Sanofi and Regeneron's Dupixent has become the first biologic drug to show activity in prurigo nodularis (PN), raising the hope of a new treatment option for the rare and highly debilitating skin ...